Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,05 USD | -0,47 % | -5,41 % | 0,00 % |
01/04 | Quince Therapeutics, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023 | CI |
26/03 | Transcript : Quince Therapeutics, Inc. - Special Call |
Resumen de negocios
Número de empleados: 32
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Dirk Thye
CEO | Chief Executive Officer | 54 | 19/05/22 |
Brendan Hannah
DFI | Director of Finance/CFO | 39 | 01/05/22 |
Charles Ryan
PSD | President | 60 | 01/09/23 |
Maureen M. Roden
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
Stacy Roughan
IRC | Investor Relations Contact | - | - |
Gary Ward
PRN | Corporate Officer/Principal | - | 01/08/22 |
Human Resources Officer | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Una Ryan
BRD | Director/Board Member | 82 | 01/03/18 |
Luca Benatti
BRD | Director/Board Member | 63 | 23/10/23 |
Dirk Thye
CEO | Chief Executive Officer | 54 | 19/05/22 |
David Lamond
CHM | Chairman | 49 | 01/12/15 |
Rajiv Patni
BRD | Director/Board Member | 55 | 15/02 |
Director/Board Member | 56 | 01/03/19 | |
Director/Board Member | 61 | 01/12/15 | |
June Bray
BRD | Director/Board Member | 70 | 09/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 43 215 233 | 35 841 506 ( 82,94 %) | 0 | 82,94 % |
Información de la empresa
Quince Therapeutics, Inc.
611 Gateway Boulevard Suite 273
94080, South San Francisco
+
http://quincetx.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
0,00 % | 45,59 M | |
+0,92 % | 42,86 mil M | |
+13,00 % | 42,74 mil M | |
+44,98 % | 41,36 mil M | |
-6,20 % | 27,68 mil M | |
+6,63 % | 25,15 mil M | |
-23,30 % | 18,63 mil M | |
+29,28 % | 12,37 mil M | |
-2,95 % | 11,92 mil M | |
+7,11 % | 11,21 mil M |
- Bolsa de valores
- Acciones
- Acción QNCX
- Empresa Quince Therapeutics, Inc.